Ironridge Global Partners is a long-only small cap institutional direct equity investor.

Ironridge Global entered into financing transactions ranging in size from a quarter million up to sixteen million dollars per issuer, ranging from exchange-listed companies on NASDAQ and NYSE to OTCQB and non-reporting OTC companies. Most of Ironridge Global’s transactions were for common stock with no warrants, rights of first refusal or other restrictive covenants. Ironridge Global has never shorted a single share of any company’s stock, and the firm remains a shareholder of every portfolio company it has invested in since inception. Ironridge Global’s principals have handled several hundred billion dollars in public company financing transactions over more than two decades. The firm’s partners have extensive industry experience including but not limited to: life sciences, biotechnology, medical devices, clean technology, energy, oil & gas, mining, natural resources, consumer products, media and technology.